相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Immune checkpoint inhibitors: Key trials and an emerging role in breast cancer
Nicola Gaynor et al.
SEMINARS IN CANCER BIOLOGY (2022)
Theranostic nanoparticles with disease-specific administration strategies
Peisen Zhang et al.
NANO TODAY (2022)
Engineering ROS-Responsive Bioscaffolds for Disrupting Myeloid Cell-Driven Immunosuppressive Niche to Enhance PD-L1 Blockade-Based Postablative Immunotherapy
Shaoyue Li et al.
ADVANCED SCIENCE (2022)
The Intracellular and Extracellular Microenvironment of Tumor Site: The Trigger of Stimuli-Responsive Drug Delivery Systems
Xiaodong Jing et al.
SMALL METHODS (2022)
Gold-seaurchin based immunomodulator enabling photothermal intervention and aCD16 transfection to boost NK cell adoptive immunotherapy
Xinyi Lin et al.
ACTA BIOMATERIALIA (2022)
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
Mengling Wu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)
Nanoparticle-enhanced radiotherapy synergizes with PD-L1 blockade to limit post-surgical cancer recurrence and metastasis
Xin Guan et al.
NATURE COMMUNICATIONS (2022)
Down-regulation of MLLT1 super elongation complex subunit impairs the anti-tumor activity of natural killer cells in esophageal cancer
Chong Liu et al.
IMMUNOBIOLOGY (2022)
Identification and biotin receptor-mediated activity of a novel seleno-biotin compound that inhibits viability of and induces apoptosis in ovarian cancer cells
Asif Raza et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2022)
Genetically engineered exosomes for targetedly preventing premetastatic niche formation and suppressing postoperative melanoma lung metastasis
Xiaoqing Han et al.
NANO TODAY (2022)
Biosynthetic cell membrane vesicles to enhance TRAIL-mediated apoptosis driven by photo-triggered oxidative stress
Feida Li et al.
BIOMATERIALS SCIENCE (2022)
Small molecule inhibitors targeting the PD-1/PD-L1 signaling pathway
Qian Wu et al.
ACTA PHARMACOLOGICA SINICA (2021)
Tailoring Chemoimmunostimulant Bioscaffolds for Inhibiting Tumor Growth and Metastasis after Incomplete Microwave Ablation
Yuting Shen et al.
ACS NANO (2021)
Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance
Sreya Bagchi et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 16, 2021 (2021)
Ultrafast Directional Janus Pt-Mesoporous Silica Nanomotors for Smart Drug Delivery
Paula Diez et al.
ACS NANO (2021)
Emerging nanotechnological strategies to reshape tumor microenvironment for enhanced therapeutic outcomes of cancer immunotherapy
Xinyi Lin et al.
BIOMEDICAL MATERIALS (2021)
CXCL9-expressing tumor-associated macrophages: new players in the fight against cancer
Paola Marie Marcovecchio et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
The Chemokine-Based Peptide, CXCL9(74-103), Inhibits Angiogenesis by Blocking Heparan Sulfate Proteoglycan-Mediated Signaling of Multiple Endothelial Growth Factors
Alexandra De Zutter et al.
CANCERS (2021)
Irradiation Mediates IFNα and CXCL9 Expression in Non-Small Cell Lung Cancer to Stimulate CD8+ T Cells Activity and Migration toward Tumors
Chun-Chia Cheng et al.
BIOMEDICINES (2021)
Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors
Baharak Bahmani et al.
NATURE COMMUNICATIONS (2021)
Hypoxia-responsive nanoreactors based on self-enhanced photodynamic sensitization and triggered ferroptosis for cancer synergistic therapy
Xiaoyan Wang et al.
JOURNAL OF NANOBIOTECHNOLOGY (2021)
Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy
Tianyu Tang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Localized NIR-II photo-immunotherapy through the combination of photothermal ablation and in situ generated interleukin-12 cytokine for efficiently eliminating primary and abscopal tumors
Xinyi Lin et al.
NANOSCALE (2021)
Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade
Imran G. House et al.
CLINICAL CANCER RESEARCH (2020)
Janus Magnetic-Plasmonic Nanoparticles for Magnetically Guided and Thermally Activated Cancer Therapy
Ana Espinosa et al.
SMALL (2020)
Resistance to Checkpoint Inhibition in Cancer Immunotherapy
Luisa Barrueto et al.
TRANSLATIONAL ONCOLOGY (2020)
Immune checkpoint signaling and cancer immunotherapy
Xing He et al.
CELL RESEARCH (2020)
Advances in engineering local drug delivery systems for cancer immunotherapy
Peter Abdou et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2020)
CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond
Nathan Karin
FRONTIERS IN IMMUNOLOGY (2020)
Ultrasound-Driven Biomimetic Nanosystem Suppresses Tumor Growth and Metastasis through Sonodynamic Therapy, CO Therapy, and Indoleamine 2,3-Dioxygenase Inhibition
Da Zhang et al.
ACS NANO (2020)
Converting Immune Cold into Hot by Biosynthetic Functional Vesicles to Boost Systematic Antitumor Immunity
Ming Wu et al.
ISCIENCE (2020)
The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies
Shogo Kumagai et al.
NATURE IMMUNOLOGY (2020)
Rerouting engineered metal-dependent shapes of mesoporous silica nanocontainers to biodegradable Janus-type (sphero-ellipsoid) nanoreactors for chemodynamic therapy
Chen-Guang Liu et al.
CHEMICAL ENGINEERING JOURNAL (2019)
Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors
Denarda Dangaj et al.
CANCER CELL (2019)
Multifunctional Nanoregulator Reshapes Immune Microenvironment and Enhances Immune Memory for Tumor Immunotherapy
Meng Yu et al.
ADVANCED SCIENCE (2019)
Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence
Fan Zhang et al.
ACTA BIOMATERIALIA (2019)
Janus Nanobullets Combine Photodynamic Therapy and Magnetic Hyperthermia to Potentiate Synergetic Anti-Metastatic Immunotherapy
Zheng Wang et al.
ADVANCED SCIENCE (2019)
PD-L1 Distribution and Perspective for Cancer Immunotherapy-Blockade, Knockdown, or Inhibition
Yilun Wu et al.
FRONTIERS IN IMMUNOLOGY (2019)
CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review
Bagher Farhood et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Jerome Galon et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Photoresponsive Nanovehicle for Two Independent Wavelength Light-Triggered Sequential Release of P-gp shRNA and Doxorubicin To Optimize and Enhance Synergistic Therapy of Multidrug-Resistant Cancer
Ming Wu et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Photo-responsive hollow silica nanoparticles for light-triggered genetic and photodynamic synergistic therapy
Xinyi Lin et al.
ACTA BIOMATERIALIA (2018)
Tumor-Repopulating Cells Induce PD-1 Expression in CD8(+) T Cells by Transferring Kynurenine and AhR Activation
Yuying Liu et al.
CANCER CELL (2018)
CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy
Ryuma Tokunaga et al.
CANCER TREATMENT REVIEWS (2018)
Dual drug delivery and sequential release by amphiphilic Janus nanoparticles for liver cancer theranostics
Lingyu Zhang et al.
BIOMATERIALS (2018)
Tailored Surfaces on 2D Material: UFO-Like Cyclodextrin-Pd Nanosheet/Metal Organic Framework Janus Nanoparticles for Synergistic Cancer Therapy
Lingyu Zhang et al.
ADVANCED FUNCTIONAL MATERIALS (2018)
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
Nisha Nagarsheth et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Anti-PD-L1 Efficacy Can Be Enhanced by Inhibition of Myeloid-Derived Suppressor Cells with a Selective Inhibitor of PI3Kδ/γ
Ruth J. Davis et al.
CANCER RESEARCH (2017)
Redox-Responsive and Drug-Embedded Silica Nanoparticles with Unique Self-Destruction Features for Efficient Gene/Drug Codelivery
Qing Zhang et al.
ADVANCED FUNCTIONAL MATERIALS (2017)
CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer
Holger Bronger et al.
BRITISH JOURNAL OF CANCER (2016)
Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells
Olivier De Henau et al.
NATURE (2016)
PI3Kγ is a molecular switch that controls immune suppression
Megan M. Kaneda et al.
NATURE (2016)
Global Gene Expression Analysis of Cellular Death Mechanisms Induced by Mesoporous Silica Nanoparticle-Based Drug Delivery System
Xiaoyu Li et al.
ACS NANO (2014)
Anisotropic Growth-Induced Synthesis of Dual-Compartment Janus Mesoporous Silica Nanoparticles for Bimodal Triggered Drugs Delivery
Xiaomin Li et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
A nanoparticle-based strategy for the imaging of a broad range of tumours by nonlinear amplification of microenvironment signals
Yiguang Wang et al.
NATURE MATERIALS (2014)
Controllable Drug Release and Simultaneously Carrier Decomposition of SiO2-Drug Composite Nanoparticles
Silu Zhang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
Chemokine Cxcl9 attenuates liver fibrosis-associated angiogenesis in mice
Hacer Sahin et al.
HEPATOLOGY (2012)
Receptor Tyrosine Kinases and TLR/IL1 Rs Unexpectedly Activate Myeloid Cell PI3Kγ, A Single Convergent Point Promoting Tumor Inflammation and Progression
Michael C. Schmid et al.
CANCER CELL (2011)
Redox-cleavable star cationic PDMAEMA by arm-first approach of ATRP as a nonviral vector for gene delivery
Fengying Dai et al.
BIOMATERIALS (2010)
Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy
RK Jain
SCIENCE (2005)